Taiwan FDA registration 8b48403b4e02121d9b2c7a1e75e0941f
Revia's biochemical and electrolyte analyzer series
TW: 露華生化暨電解質分析儀系列
Taiwan·Risk Class 2·NOVA BIOMEDICAL CORPORATION·Registered Feb 27, 2006 – Feb 27, 2026ExpiredRegistration details
- Analysis ID
- 8b48403b4e02121d9b2c7a1e75e0941f
- Customs Code
- DHA00601606205
Company information
- Manufacturer
- NOVA BIOMEDICAL CORPORATION
- Manufacturer Country
- United States
- Authorized Representative
- BEAM INTERNATIONAL INC.
Product details
- Intended Use
- CRT measures the pH of serum, plasma, cerebrospinal fluid, whole blood and urine, as well as oxygen, carbon dioxide, sodium, potassium, calcium, chloride, glucose, magnesium, lithium, urea nitrogen, creatinine and heme.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1120 血內氣體(PCO2,PO2)及血液pH值試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Feb 27, 2006
- Expiry Date
- Feb 27, 2026
About this record
Access comprehensive regulatory information for Revia's biochemical and electrolyte analyzer series in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8b48403b4e02121d9b2c7a1e75e0941f and manufactured by NOVA BIOMEDICAL CORPORATION. The authorized representative in Taiwan is BEAM INTERNATIONAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices